{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:01:19Z","timestamp":1791511279089,"version":"4.3.4"},"reference-count":167,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LZ25H090005"],"award-info":[{"award-number":["LZ25H090005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZCLZ25H2502"],"award-info":[{"award-number":["ZCLZ25H2502"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071585"],"award-info":[{"award-number":["82071585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271282"],"award-info":[{"award-number":["82271282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471617"],"award-info":[{"award-number":["82471617"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tjnut.2025.01.028","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:50:56Z","timestamp":1738407056000},"page":"1019-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epidemiologic Risk and Prevention and Interventions in Parkinson Disease: From a Nutrition-Based Perspective"],"prefix":"10.1016","volume":"155","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samwel Sylvester","family":"Msigwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hai","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9412-8264","authenticated-orcid":false,"given":"Jian-Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjnut.2025.01.028_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.603854","article-title":"Prevalence of Alzheimer\u2019s disease and Parkinson\u2019s disease in China: an updated systematical analysis","volume":"12","author":"Cui","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.tjnut.2025.01.028_bib4","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.tjnut.2025.01.028_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.24000","article-title":"Dopamine transporter imaging in autopsy-confirmed Parkinson\u2019s disease and multiple system atrophy","volume":"27","author":"Perju-Dumbrava","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tjnut.2025.01.028_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.tjnut.2025.01.028_bib9","article-title":"Trends and disparities in deep brain stimulation utilization in the United States: a Nationwide Inpatient Sample analysis from 1993 to 2017","volume":"26","author":"Sarica","year":"2023","journal-title":"Lancet Reg. Health Am"},{"key":"10.1016\/j.tjnut.2025.01.028_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-023-02557-1","article-title":"Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges","volume":"145","author":"Dutta","year":"2023","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib13","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/brain\/awac115","article-title":"Detection of neuron-derived pathological alpha-synuclein in blood","volume":"145","author":"Kluge","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.tjnut.2025.01.028_bib14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib15","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","article-title":"Wearable movement-tracking data identify Parkinson\u2019s disease years before clinical diagnosis","volume":"29","author":"Schalkamp","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41586-023-06555-x","article-title":"A\u00a0foundation model for generalizable disease detection from retinal images","volume":"622","author":"Zhou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tjnut.2025.01.028_bib17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41531-023-00456-6","article-title":"Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson\u2019s disease in Chinese population","volume":"9","author":"Pan","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tjnut.2025.01.028_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaneurol.2020.0428","article-title":"Identification of risk loci for Parkinson disease in Asians and comparison of risk between Asians and Europeans: a genome-wide association study","volume":"77","author":"Foo","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib22","doi-asserted-by":"crossref","first-page":"159.e7","DOI":"10.1016\/j.neurobiolaging.2018.03.005","article-title":"Association analyses of variants of SIPA1L2, MIR4697, GCH1, VPS13C, and DDRGK1 with Parkinson\u2019s disease in East Asians","volume":"68","author":"Zou","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tjnut.2025.01.028_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s43587-024-00760-7","article-title":"Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson\u2019s disease risk","author":"Chew","year":"2024","journal-title":"Nat. Aging."},{"key":"10.1016\/j.tjnut.2025.01.028_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet."},{"key":"10.1016\/j.tjnut.2025.01.028_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.conb.2017.08.004","article-title":"Striatal synapses, circuits, and Parkinson\u2019s disease","volume":"48","author":"Zhai","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-019-02010-2","article-title":"Selective vulnerability in alpha-synucleinopathies","volume":"138","author":"Alegre-Abarrategui","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib27","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tjnut.2025.01.028_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","article-title":"Alpha-synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading","volume":"134","author":"Loria","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib29","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/538S13a","article-title":"Pathology: the prion principle","volume":"538","author":"Makin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tjnut.2025.01.028_bib30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/brain\/awaa096","article-title":"Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates","volume":"143","author":"Arotcarena","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tjnut.2025.01.028_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson\u2019s disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib33","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.tjnut.2025.01.028_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/aje\/kwr451","article-title":"Caffeine intake, smoking, and risk of Parkinson disease in men and women","volume":"175","author":"Liu","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib36","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","article-title":"Caffeine and risk of Parkinson\u2019s disease in a large cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib37","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","article-title":"Smoking, alcohol, and coffee consumption preceding Parkinson\u2019s disease: a case-control study","volume":"55","author":"Benedetti","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JPD-171175","article-title":"Differences in Parkinson\u2019s disease risk with caffeine intake and postmenopausal hormone use","volume":"7","author":"Kim","year":"2017","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.tjnut.2025.01.028_bib39","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.29778","article-title":"Contribution of nutritional, lifestyle, and metabolic risk factors to Parkinson\u2019s disease","volume":"39","author":"Veronese","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib40","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209201","article-title":"Association of coffee consumption and prediagnostic caffeine metabolites with incident Parkinson disease in a population-based cohort","volume":"102","author":"Zhao","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/aje\/155.8.732","article-title":"Parkinson\u2019s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake","volume":"155","author":"Checkoway","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/mds.870070407","article-title":"Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson\u2019s disease: a case-control study","volume":"7","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1992","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.20307","article-title":"Risk and protective factors for Parkinson\u2019s disease: a study in Swedish twins","volume":"57","author":"Wirdefeldt","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/aje\/kwh312","article-title":"Coffee consumption, gender, and Parkinson\u2019s disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen","volume":"160","author":"Ascherio","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2003.07.006","article-title":"Dose-dependent protective effect of coffee, tea, and smoking in Parkinson\u2019s disease: a study in ethnic Chinese","volume":"216","author":"Tan","year":"2003","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/aje\/kwm338","article-title":"Differential effects of black versus green tea on risk of Parkinson\u2019s disease in the Singapore Chinese Health Study","volume":"167","author":"Tan","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.parkreldis.2011.02.016","article-title":"Intake of Japanese and Chinese teas reduces risk of Parkinson\u2019s disease","volume":"17","author":"Tanaka","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.tjnut.2025.01.028_bib48","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3233\/JPD-223148","article-title":"Independent and joint associations of tea consumption and smoking with Parkinson\u2019s disease risk in Chinese Adults","volume":"12","author":"Nie","year":"2022","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.tjnut.2025.01.028_bib49","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.21706","article-title":"Coffee and tea consumption and the risk of Parkinson\u2019s disease","volume":"22","author":"Hu","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000054770","article-title":"Risk factors for Parkinson\u2019s disease: the leisure world cohort study","volume":"20","author":"Paganini-Hill","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jnnp.45.7.577","article-title":"Smoking and Parkinson\u2019s disease","volume":"45","author":"Godwin-Austen","year":"1982","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.tjnut.2025.01.028_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","article-title":"Nutritional and occupational factors influencing the risk of Parkinson\u2019s disease: a case-control study in southeastern Sweden","volume":"14","author":"Fall","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson\u2019s disease: a case-control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.10611","article-title":"Alcohol consumption and the incidence of Parkinson\u2019s disease","volume":"54","author":"Hern\u00e1n","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib55","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/mds.25050","article-title":"Alcohol and risk of Parkinson\u2019s disease in a large, prospective cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib56","article-title":"Alcohol consumption, types of alcohol, and Parkinson\u2019s disease","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tjnut.2025.01.028_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00578-0","article-title":"Risk factors of Parkinson\u2019s disease in Indian patients","volume":"190","author":"Behari","year":"2001","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib58","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/mds.28039","article-title":"Alcohol Consumption and Risk of Parkinson\u2019s Disease: Data From a Large Prospective European Cohort","volume":"35","author":"Peters","year":"2020","journal-title":"Mov. Disord."},{"issue":"Suppl 7","key":"10.1016\/j.tjnut.2025.01.028_bib59","first-page":"vII14","article-title":"A\u00a0prospective study of alcoholism and the risk of Parkinson\u2019s disease","volume":"251","author":"Hern\u00e1n","year":"2004","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mds.27933","article-title":"Alcohol intake and Parkinson\u2019s disease risk in the Million Women Study","volume":"35","author":"Kim","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1368980007000419","article-title":"Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study","volume":"11","author":"Thompson","year":"2008","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.tjnut.2025.01.028_bib62","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ana.10381","article-title":"Diet and Parkinson\u2019s disease: a potential role of dairy products in men","volume":"52","author":"Chen","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib63","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwk089","article-title":"Consumption of dairy products and risk of Parkinson\u2019s disease","volume":"165","author":"Chen","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1212\/01.WNL.0000154532.98495.BF","article-title":"Consumption of milk and calcium in midlife and the future risk of Parkinson disease","volume":"64","author":"Park","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S0007114512000955","article-title":"A\u00a0cohort study on diet and the risk of Parkinson\u2019s disease: the role of food groups and diet quality","volume":"109","author":"S\u00e4\u00e4ksj\u00e4rvi","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.tjnut.2025.01.028_bib66","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s10654-024-01152-2","article-title":"Consumption of milk and other dairy products and incidence of Parkinson\u2019s disease: a prospective cohort study in French women","volume":"39","author":"Hajji-Louati","year":"2024","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-012-9760-0","article-title":"Dietary and lifestyle variables in relation to incidence of Parkinson\u2019s disease in Greece","volume":"28","author":"Kyrozis","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0000000000004057","article-title":"Intake of dairy foods and risk of Parkinson disease","volume":"89","author":"Hughes","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib69","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/aje\/kwg073","article-title":"Dietary intakes of fat and risk of Parkinson\u2019s disease","volume":"157","author":"Chen","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib70","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2009.09.021","article-title":"Dietary fat intake and risk of Parkinson\u2019s disease: a case-control study in Japan","volume":"288","author":"Miyake","year":"2010","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib71","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.26032","article-title":"Dietary fat intake and risk for Parkinson\u2019s disease","volume":"29","author":"Dong","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib72","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-022-00863-8","article-title":"Dietary fat intake and risk of Parkinson disease: results from the Swedish National March Cohort","volume":"37","author":"Hantikainen","year":"2022","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib73","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: the Rotterdam Study","volume":"64","author":"de Lau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib74","first-page":"III30","article-title":"Environmental, life-style, and physical precursors of clinical Parkinson\u2019s disease: recent findings from the Honolulu-Asia Aging Study","volume":"250","author":"Abbott","year":"2003","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib75","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2013.09.023","article-title":"Dietary fat intake, pesticide use, and Parkinson\u2019s disease","volume":"20","author":"Kamel","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1123239","article-title":"Associations between polyunsaturated fatty acid concentrations and Parkinson\u2019s disease: a two-sample Mendelian randomization study","volume":"15","author":"Zhu","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib77","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/mds.28173","article-title":"Dietary antioxidants and risk of Parkinson\u2019s disease in the Singapore Chinese Health Study","volume":"35","author":"Ying","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib78","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1212\/01.WNL.0000068021.13945.7F","article-title":"Parkinson\u2019s disease risks associated with dietary iron, manganese, and other nutrient intakes","volume":"60","author":"Powers","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/aje\/kwh213","article-title":"Folate intake and risk of Parkinson\u2019s disease","volume":"160","author":"Chen","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib80","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.wnl.0000225050.57553.6d","article-title":"Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease","volume":"67","author":"de Lau","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib81","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/mds.26819","article-title":"Intake of antioxidant vitamins and risk of Parkinson\u2019s disease","volume":"31","author":"Hughes","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib82","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/mds.27120","article-title":"Dietary antioxidants and risk of Parkinson\u2019s disease in two population-based cohorts","volume":"32","author":"Yang","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib83","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1631\/jzus.B1400005","article-title":"Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson\u2019s disease","volume":"15","author":"Zhu","year":"2014","journal-title":"J.\u00a0Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.tjnut.2025.01.028_bib84","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3182a95818","article-title":"Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study","volume":"81","author":"Ding","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib85","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mds.26117","article-title":"Vitamin D from different sources is inversely associated with Parkinson disease","volume":"30","author":"Wang","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib86","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneurol.2010.120","article-title":"Serum vitamin D and the risk of Parkinson disease","volume":"67","author":"Knekt","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib87","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mds.26573","article-title":"Serum 25-hydroxyvitamin D concentrations in mid-adulthood and Parkinson\u2019s disease risk","volume":"31","author":"Shrestha","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib88","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/01.WNL.0000028688.75881.12","article-title":"Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk","volume":"59","author":"Zhang","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1468-1331.2010.03088.x","article-title":"Dietary intake of antioxidant vitamins and risk of Parkinson\u2019s disease: a case\u2013control study in Japan","volume":"18","author":"Miyake","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib90","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ajcn\/86.5.1486","article-title":"Prospective study of dietary pattern and risk of Parkinson disease","volume":"86","author":"Gao","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tjnut.2025.01.028_bib91","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1468-1331.2011.03600.x","article-title":"Dietary patterns and risk of Parkinson\u2019s disease: a case\u2013control study in Japan","volume":"19","author":"Okubo","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib92","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.29580","article-title":"Plant-based dietary patterns and Parkinson\u2019s disease: a prospective analysis of the UK Biobank","volume":"38","author":"Tresserra-Rimbau","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib93","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/mds.24918","article-title":"The association between Mediterranean diet adherence and Parkinson\u2019s disease","volume":"27","author":"Alcalay","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib94","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.27489","article-title":"Mediterranean diet adherence is related to reduced probability of prodromal Parkinson\u2019s disease","volume":"34","author":"Maraki","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib95","doi-asserted-by":"crossref","first-page":"e2095","DOI":"10.1212\/WNL.0000000000010523","article-title":"Diet pattern and prodromal features of Parkinson disease","volume":"95","author":"Molsberry","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib96","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.28464","article-title":"MIND and Mediterranean diets associated with later onset of Parkinson\u2019s disease","volume":"36","author":"Metcalfe-Roach","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib97","first-page":"1211","article-title":"MIND diet associated with reduced incidence and delayed progression of parkinsonism in old age, J Nutr","volume":"22","author":"Agarwal","year":"2018","journal-title":"Health Aging"},{"key":"10.1016\/j.tjnut.2025.01.028_bib98","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1468-1331.2008.02236.x","article-title":"Body mass index does not change before Parkinson\u2019s disease onset","volume":"15","author":"Ragonese","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib99","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/mds.23855","article-title":"Obesity, diabetes, and risk of Parkinson\u2019s disease","volume":"26","author":"Palacios","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib100","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/mds.25016","article-title":"Metabolic markers or conditions preceding Parkinson\u2019s disease: a case-control study","volume":"27","author":"Savica","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib101","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10654-014-9887-2","article-title":"Reduced risk of Parkinson\u2019s disease associated with lower body mass index and heavy leisure-time physical activity","volume":"29","author":"S\u00e4\u00e4ksj\u00e4rvi","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib102","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1212\/WNL.0000000000005328","article-title":"Body mass index, sitting time, and risk of Parkinson disease","volume":"90","author":"Roos","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib103","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson\u2019s disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-022-00353-4","article-title":"Waist circumference and risk of Parkinson\u2019s disease","volume":"8","author":"Park","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.tjnut.2025.01.028_bib105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.59.7.1051","article-title":"Midlife adiposity and the future risk of Parkinson\u2019s disease","volume":"59","author":"Abbott","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib106","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000247052.18422.e5","article-title":"Body mass index and the risk of Parkinson disease","volume":"67","author":"Hu","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib107","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mds.27922","article-title":"Body mass index, diabetes, and the risk of Parkinson\u2019s disease","volume":"35","author":"Jeong","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib108","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1212\/WNL.0000000000004691","article-title":"Early weight loss in parkinsonism predicts poor outcomes: evidence from an incident cohort study","volume":"89","author":"Cumming","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib109","article-title":"Meta-analysis of brain iron levels of Parkinson\u2019s disease patients determined by postmortem and MRI measurements","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tjnut.2025.01.028_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s12264-018-0209-7","article-title":"Iron, Dopamine, and \u03b1-synuclein interactions in at-risk dopaminergic neurons in Parkinson\u2019s disease","volume":"34","author":"Song","year":"2018","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.tjnut.2025.01.028_bib111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2013.00167","article-title":"Regional siderosis: a new challenge for iron chelation therapy","volume":"4","author":"Cabantchik","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib112","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMra1800219","article-title":"The role of deferiprone in iron chelation","volume":"379","author":"Hider","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib113","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tjnut.2025.01.028_bib114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-015-0331-3","article-title":"Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease","volume":"15","author":"Grolez","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib115","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tjnut.2025.01.028_bib116","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in Parkinson\u2019s disease","volume":"387","author":"Devos","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.602697","article-title":"Caffeine and Parkinson\u2019s disease: multiple benefits and emerging mechanisms","volume":"14","author":"Ren","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib118","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/01.wnl.0000233916.57415.9d","article-title":"Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease","volume":"67","author":"Deleu","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib119","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mds.21208","article-title":"Effects of caffeine on the freezing of gait in Parkinson\u2019s disease","volume":"22","author":"Kitagawa","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib120","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/mds.23873","article-title":"Caffeine in Parkinson\u2019s disease: a pilot open-label, dose-escalation study","volume":"26","author":"Altman","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib121","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: a randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib122","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/WNL.0000000000004568","article-title":"Caffeine as symptomatic treatment for Parkinson disease (Caf\u00e9-PD): a randomized trial","volume":"89","author":"Postuma","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib123","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v4i2.826","article-title":"Motor improvement in Parkinson\u2019s disease patients receiving caffeine adjuvants: a double-blind randomized controlled trial in Indonesia","volume":"4","author":"Hamdan","year":"2024","journal-title":"Narra J"},{"key":"10.1016\/j.tjnut.2025.01.028_bib124","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2005.02.002","article-title":"Therapeutic role of coenzyme Q(10) in Parkinson\u2019s disease","volume":"107","author":"Shults","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tjnut.2025.01.028_bib125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2004.05.003","article-title":"Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson\u2019s disease","volume":"188","author":"Shults","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib126","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/ars.2013.5801","article-title":"Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson\u2019s disease?","volume":"21","author":"Seet","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tjnut.2025.01.028_bib128","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.parkreldis.2015.05.022","article-title":"Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson\u2019s disease","volume":"21","author":"Yoritaka","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl","key":"10.1016\/j.tjnut.2025.01.028_bib129","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/S0098-2997(97)00008-3","article-title":"Q10 therapy in patients with idiopathic Parkinson\u2019s disease","volume":"18","author":"Strijks","year":"1997","journal-title":"Mol. Aspects. Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson\u2019s disease","volume":"341","author":"M\u00fcller","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tjnut.2025.01.028_bib131","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A\u00a0randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit","volume":"71","author":"Beal","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib132","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A\u00a0double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib133","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease","volume":"64","author":"Storch","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib134","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000377676","article-title":"The effect of creatine and coenzyme q10 combination therapy on mild cognitive impairment in Parkinson\u2019s disease","volume":"73","author":"Li","year":"2015","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib135","first-page":"183","article-title":"The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial, Neurochem","volume":"108","author":"Taghizadeh","year":"2017","journal-title":"Int."},{"key":"10.1016\/j.tjnut.2025.01.028_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106954","article-title":"Neuroaspis PLP10\u2122, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"210","author":"Pantzaris","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.tjnut.2025.01.028_bib137","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"da Silva","year":"2008","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib138","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.wnf.0000150865.21759.bc","article-title":"The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease","volume":"27","author":"Nagayama","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.tjnut.2025.01.028_bib139","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson\u2019s disease","volume":"328","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib140","doi-asserted-by":"crossref","first-page":"380s","DOI":"10.1093\/ajcn\/53.1.380S","article-title":"An open trial of high-dosage antioxidants in early Parkinson\u2019s disease","volume":"53","author":"Fahn","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tjnut.2025.01.028_bib141","first-page":"145","article-title":"A\u00a0clinical trial of folic acid in Parkinson\u2019s disease","volume":"106","author":"McGeer","year":"1972","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.tjnut.2025.01.028_bib142","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jocn.2021.03.047","article-title":"Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson\u2019s disease patients: a randomized controlled study","volume":"88","author":"Anamnart","year":"2021","journal-title":"J.\u00a0Clin. Neurosci"},{"key":"10.1016\/j.tjnut.2025.01.028_bib143","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000219815.83681.f7","article-title":"Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study","volume":"66","author":"Postuma","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib144","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mds.22866","article-title":"Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson\u2019s disease","volume":"25","author":"Lee","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib145","first-page":"740","article-title":"Long-term treatment with high-dose thiamine in Parkinson disease: an open-label pilot study, J. Altern. Complement","volume":"21","author":"Costantini","year":"2015","journal-title":"Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib146","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","article-title":"Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease","volume":"97","author":"Suzuki","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tjnut.2025.01.028_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203637","article-title":"A\u00a0randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson\u2019s disease: does age matter?","volume":"13","author":"Hiller","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tjnut.2025.01.028_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210200","article-title":"Effect of 12-week BMI-based vitamin D(3) supplementation in Parkinson\u2019s disease with deep brain stimulation on physical performance, inflammation, and vitamin D metabolites","volume":"24","author":"Bytowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tjnut.2025.01.028_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102366","article-title":"The effect of the Mediterranean diet on cognitive function in patients with Parkinson\u2019s disease: a randomized clinical controlled trial","volume":"50","author":"Paknahad","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.tjnut.2025.01.028_bib150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/1028415X.2020.1751509","article-title":"The effects of Mediterranean diet on severity of disease and serum total antioxidant capacity (TAC) in patients with Parkinson\u2019s disease: a single center, randomized controlled trial","volume":"25","author":"Paknahad","year":"2022","journal-title":"Nutr. Neurosci"},{"key":"10.1016\/j.tjnut.2025.01.028_bib151","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3390\/nu16172946","article-title":"Promotion of a Mediterranean diet alters constipation symptoms and fecal calprotectin in people with Parkinson\u2019s disease: a randomized controlled trial","volume":"16","author":"Rusch","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.tjnut.2025.01.028_bib152","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.14336\/AD.2021.1217","article-title":"Effects of ketogenic diet on neuroinflammation in neurodegenerative diseases","volume":"13","author":"Jiang","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.tjnut.2025.01.028_bib153","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"64","author":"Itallie","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib154","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson\u2019s disease: a\u00a0pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tjnut.2025.01.028_bib155","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s13760-020-01486-0","article-title":"Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson\u2019s disease","volume":"121","author":"Koyuncu","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.tjnut.2025.01.028_bib156","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12883-024-03603-5","article-title":"A\u00a0randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson\u2019s disease","volume":"24","author":"Choi","year":"2024","journal-title":"BMC Neurol"},{"key":"10.1016\/j.tjnut.2025.01.028_bib157","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.tjnut.2025.01.028_bib158","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.tjnut.2025.01.028_bib159","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","article-title":"An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants","volume":"14","author":"Hall","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tjnut.2025.01.028_bib160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","article-title":"Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson\u2019s disease\u2014the RESISTA-PD trial","volume":"20","author":"Becker","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.tjnut.2025.01.028_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-74400-w","article-title":"Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson\u2019s disease: results from an open label single-arm study","volume":"14","author":"Andreozzi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tjnut.2025.01.028_bib162","first-page":"289","article-title":"The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: a randomized, double-blind, placebo controlled trial, Arch","volume":"21","author":"Borzabadi","year":"2018","journal-title":"Iran Med"},{"key":"10.1016\/j.tjnut.2025.01.028_bib163","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT","volume":"87","author":"Barichella","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244680","article-title":"Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: a randomised controlled trial","volume":"15","author":"Ibrahim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tjnut.2025.01.028_bib165","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1212\/WNL.0000000000010998","article-title":"Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study","volume":"96","author":"Tan","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.tjnut.2025.01.028_bib166","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00213-024-06606-9","article-title":"Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson\u2019s disease: a randomized controlled clinical trial","volume":"241","author":"Zali","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.tjnut.2025.01.028_bib167","first-page":"1507","article-title":"Advice to people with Parkinson\u2019s in my clinic: probiotics and prebiotics, J","volume":"14","author":"Hor","year":"2024","journal-title":"Parkinsons Dis."}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316625000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316625000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:50:15Z","timestamp":1775004615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316625000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":167,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0022316625000355"],"URL":"https:\/\/doi.org\/10.1016\/j.tjnut.2025.01.028","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiologic Risk and Prevention and Interventions in Parkinson Disease: From a Nutrition-Based Perspective","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjnut.2025.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Nutrition. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}